Characterization and optimization of the glucan particle-based vaccine platform

Clinical and Vaccine Immunology

Volumn 20, Issue 10, 2013, Pages 1585-1591

  Huang, Haibin ^a   Ostroff, Gary R ^a   Lee, Chrono K ^a   Specht, Charles A ^a   Levitz, Stuart M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CALCIUM; CHITOSAN; FUNGUS VACCINE; GAMMA INTERFERON; GLUCAN PARTICLE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2C; INTERLEUKIN 17; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; T LYMPHOCYTE ACTIVATION; VACCINE PRODUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG CARRIERS; GLUCANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; OVALBUMIN; SACCHAROMYCES CEREVISIAE; VACCINATION; VACCINES;

EID: 84886732691     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00463-13     Document Type: Article

References (21)

1. Levitz SM, Golenbock DT. 2012. Beyond empiricism: informing vaccine development through innate immunity research. Cell 148:1284-1292.
2. Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. 2010. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. mBio 1(3):00164-10. doi:10.1128/mBio. 00164-10.
3. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. 2004. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173:797-806.
4. Bowman SM, Free SJ. 2006. The structure and synthesis of the fungal cell wall. Bioessays 28:799-808.
5. Tsoni SV, Brown GD. 2008. Beta-glucans and dectin-1. Ann. N. Y. Acad. Sci. 1143:45-60.
6. Brown GD, Gordon S. 2001. Immune recognition. A new receptor for beta-glucans. Nature 413:36-37.
7. Beller DI, Springer TA, Schreiber RD. 1982. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156:1000-1009.
8. Ezekowitz RA, Sim RB, Hill M, Gordon S. 1984. Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J. Exp. Med. 159:244-260.
9. Means TK, Mylonakis E, Tampakakis E, Colvin RA, Seung E, Puckett L, Tai MF, Stewart CR, Pukkila-Worley R, Hickman SE, Moore KJ, Calderwood SB, Hacohen N, Luster AD, El Khoury J. 2009. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206:637-653.
10. Vera J, Fenutria R, Cañadas O, Figueras M, Mota R, Sarrias MR, Williams DL, Casals C, Yelamos J, Lozano F. 2009. The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proc. Natl. Acad. Sci. U. S. A.106:1506-1511.
11. Agarwal S, Specht CA, Haibin H, Ostroff GR, Ram S, Rice PA, Levitz SM. 2011. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. mBio 2(5):00178-11. doi:10.1128/mBio. 00178-11.
12. Soto ER, Ostroff GR. 2008. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles forDNAdelivery. Bioconjug. Chem. 19:840-848.
13. Huang H, Ostroff GR, Lee CK, Agarwal S, Ram S, Rice PA, Specht CA, Levitz SM. 2012. Relative contributions of dectin-1 and complement to immune responses to particulate beta-glucans. J. Immunol. 189:312-317.
14. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630-638.
15. Xie J, Guo L, Ruan Y, Zhu H, Wang L, Zhou L, Yun X, Gu J. 2010. Laminarin-mediated targeting to Dectin-1 enhances antigen-specific immune responses. Biochem. Biophys. Res. Commun. 391:958-962.
16. Morgan EL, Thoman ML, Sanderson SD, Phillips JA. 2010. A novel adjuvant for vaccine development in the aged. Vaccine 28:8275-8279.
17. Blander JM, Medzhitov R. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808-812.
18. Manz BN, Jackson BL, Petit RS, Dustin ML, Groves J. 2011. T-cell triggering thresholds are modulated by the number of antigen within individual T-cell receptor clusters. Proc. Natl. Acad. Sci. U. S. A. 108:9089-9094.
19. Lindenstrøm T, Woodworth J, Dietrich J, Aagaard C, Andersen P, Agger EM. 2012. Vaccine-induced Th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset. Infect. Immun. 80:3533-3544.
20. Bueter CL, Lee CK, Rathinam VA, Healy GJ, Taron CH, Specht CA, Levitz SM. 2011. Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis. J. Biol. Chem. 286:35447-35455.
21. Hurtgen BJ, Hung CY, Ostroff GR, Levitz SM, Cole GT. 2012. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against coccidioidomycosis. Infect. Immun. 80:3960-3974.